|
| Exchange Received Time 19/09/2019 16:44:16 Exchange Disseminated Time 19/09/2019 16:44:23 Time Taken 00:00:07 | | Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/09/2019 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors will be held on Saturday, the 21st September 2019, to consider the report of valuation of the wholly owned subsidiary company, Nueclear Healthcare Limited (NHL), obtained from a second valuer engaged for the purpose, in the context of deciding whether to retain the Company's shareholding in NHL or dispose it of. |
|
|